Dendreon Corporation - Product Pipeline Review - 2014

Dendreon Corporation - Product Pipeline Review - 2014

Regular price $1,500.00 Sale

Published on May 30, 2014 - 32 pages

Global Markets Direct's, 'Dendreon Corporation - Product Pipeline Review - 2014', provides an overview of the Dendreon Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dendreon Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

  • The report provides brief overview of Dendreon Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Dendreon Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Dendreon Corporation's pipeline products
Reasons to buy
  • Evaluate Dendreon Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Dendreon Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Dendreon Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Dendreon Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dendreon Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Dendreon Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents
Table of Contents
List of Tables
List of Figures
Dendreon Corporation Snapshot
Dendreon Corporation Overview
Key Information
Key Facts
Dendreon Corporation - Research and Development Overview
Key Therapeutic Areas
Dendreon Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Dendreon Corporation - Pipeline Products Glance
Dendreon Corporation - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Dendreon Corporation - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Dendreon Corporation - Drug Profiles
Product Description
Mechanism of Action
R&D Progress
Product Description
Mechanism of Action
R&D Progress
Drug Targeting Carbonic Anhydrase IX
Product Description
Mechanism of Action
R&D Progress
Drug Targeting Carcinoembryonic Antigen
Product Description
Mechanism of Action
R&D Progress
Dendreon Corporation - Pipeline Analysis
Dendreon Corporation - Pipeline Products by Target
Dendreon Corporation - Pipeline Products by Route of Administration
Dendreon Corporation - Pipeline Products by Molecule Type
Dendreon Corporation - Pipeline Products by Mechanism of Action
Dendreon Corporation - Recent Pipeline Updates
Dendreon Corporation - Dormant Projects
Dendreon Corporation - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Dendreon Corporation - Company Statement
Dendreon Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Dendreon Corporation - Key Manufacturing Facilities
Secondary Research
Primary Research
Expert Panel Validation
Contact Us

List of Tables
Dendreon Corporation, Key Information
Dendreon Corporation, Key Facts
Dendreon Corporation - Pipeline by Indication, 2014
Dendreon Corporation - Pipeline by Stage of Development, 2014
Dendreon Corporation - Monotherapy Products in Pipeline, 2014
Dendreon Corporation - Phase II, 2014
Dendreon Corporation - Phase I, 2014
Dendreon Corporation - Preclinical, 2014
Dendreon Corporation - Pipeline by Target, 2014
Dendreon Corporation - Pipeline by Route of Administration, 2014
Dendreon Corporation - Pipeline by Molecule Type, 2014
Dendreon Corporation - Pipeline Products by Mechanism of Action, 2014
Dendreon Corporation - Recent Pipeline Updates, 2014
Dendreon Corporation - Dormant Developmental Projects,2014